Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Sarilumab, Tocilizumab, and Abatacept in Rheumatoid Arthritis
NCT03784261Phase 2Unknown
- Sponsor
- Shinshu University
- Start
- Dec 2018
- Primary completion
- Dec 2022
- Modality
- Antibody Conjugates, Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sarilumab, tocilizumab, abatacept in rheumatoid arthritis (RA), sponsored by Shinshu University. Status: unknown.
02
Drugs
sarilumabtocilizumababatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03784261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03784261.